Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Fondazione Telethon clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Italy register with Fondazione Telethon as lead sponsor. Synced 12 Nov 2026
4Current trials
2Recruiting now
0Drugs in these trials
1Trial register
At a glance

Fondazione Telethon is the lead sponsor of 4 current clinical trials in our Italy register. 2 are recruiting patients now. The most common phase is Phase 3. The most-studied condition is Wiskott-Aldrich Syndrome.

ClinicalTrials.gov trials by status

  • Recruiting250%
  • Active, closed125%
  • By invitation125%

Trials by phase

  • Phase 3125%
  • Phase 2125%
  • Phase 1/2125%
  • Observational125%
01

Clinical trials sponsored by Fondazione Telethon

4 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Gene-Modified Stem Cell Therapy for Subjects With Transfusion-dependent Beta-thalassemia
NCT07680803 · ClinicalTrials.gov ↗ · Transfusion-dependent Beta-Thalassemia
Phase 2 Recruiting 2026-07 Italy
Gene-Modified Stem Cell Therapy for Children With Autosomal Recessive Osteopetrosis (ARO)
NCT07665021 · ClinicalTrials.gov ↗ · Osteopetrosis
Phase 1/2 Recruiting 2026-06 Italy
Strimvelis Registry Study to Follow-up Patients With Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID)
NCT03478670 · ClinicalTrials.gov ↗ · Immunologic Deficiency Syndromes
Observational By invitation 2017-05 Italy
A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects With Wiskott-Aldrich Syndrome
NCT03837483 · ClinicalTrials.gov ↗ · Wiskott-Aldrich Syndrome
Phase 3 Active, closed 2019-01 Italy

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Fondazione Telethon trials

4 conditions
Wiskott-Aldrich Syndrome1Transfusion-dependent Beta-Thalassemia1Osteopetrosis1Immunologic Deficiency Syndromes1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Italy42

A trial with sites in more than one country appears in each of those registers.

04

Questions about Fondazione Telethon trials

How many clinical trials does Fondazione Telethon sponsor?

Fondazione Telethon is the lead sponsor of 4 current trials on ClinicalTrials.gov in our Italy register, as of the registry sync on 12 November 2026. Completed and withdrawn studies are not counted.

Are Fondazione Telethon trials recruiting?

Yes. 2 of its 4 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 12 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.